Chlamydia trachomatis Infection in Female Partners of Circumcised and Uncircumcised Adult Men
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kiviat NB, Paavonen JA, Brockway J, et al. Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA1985;253:989–96.
Smith JS, Muñoz N, Herrero R, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis2002;185:324–31.
Smith JS, Bosetti C, Muñoz N, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer2004;111:431–9.
Westrom L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis1992;19:185–92.
Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect1999;75:3–17.
Weiss GN. Prophylactic neonatal surgery and infectious diseases. Pediatr Infect Dis J1997;16:727–34.
Siegfried N, Muller M, Deeks J, et al. HIV and male circumcision—a systematic review with assessment of the quality of studies. Lancet Infect Dis2005;5:165–73.
Aynaud O, Piron D, Bijaoui G, et al. Developmental factors of urethral human papillomavirus lesions: correlation with circumcision. BJU Int1999;84:57–60.
Cook LS, Koutsky LA, Holmes KK. Circumcision and sexually transmitted diseases. Am J Public Health1994;84:197–201.
Diseker RA III, Peterman TA, Kamb ML, et al. Circumcision and STD in the United States: cross sectional and cohort analyses. Sex Transm Infect2000;76:474–9.
Hart G. Factors associated with genital chlamydial and gonococcal infection in males. Genitourin Med1993;69:393–6.
Oliver JC, Oliver RT, Ballard RC. Influence of circumcision and sexual behaviour on PSA levels in patients attending a sexually transmitted disease (STD) clinic. Prostate Cancer Prostatic Dis2001;4:228–31.
Serour F, Samra Z, Kushel Z, et al. Comparative periurethral bacteriology of uncircumcised and circumcised males. Genitourin Med1997;73:288–90.
Spach DH, Stapleton AE, Stamm WE. Lack of circumcision increases the risk of urinary tract infection in young men. JAMA1992;267:679–81.
Castellsagué X, Bosch FX, Muñoz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med2002;346:1105–12.
Bosch FX, Muñoz N, de Sanjosé S, et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev1993;2:415–22.
Bosch FX, Castellsagué X, Muñoz N, et al. Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst1996;88:1060–7.
Castellsagué X, Ghaffari A, Daniel RW, et al. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis1997;176:353–61.
Chichareon S, Herrero R, Muñoz N, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst1998;90:50–7.
Eluf-Neto J, Booth M, Muñoz N, et al. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer1994;69:114–19.
Franceschi S, Castellsagué X, Dal Maso L, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer2002;86:705–11.
Muñoz N, Bosch FX, de Sanjosé S, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer1992;52:743–9.
Muñoz N, Bosch FX, de Sanjosé S, et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev1993;2:423–31.
Muñoz N, Castellsagué X, Bosch FX, et al. Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease. J Natl Cancer Inst1996;88:1068–75.
Ngelangel C, Muñoz N, Bosch FX, et al. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst1998;90:43–9.
Bosch FX, Muñoz N, de Sanjosé S, et al. Importance of human papillomavirus endemicity in the incidence of cervical cancer: an extension of the hypothesis on sexual behavior. Cancer Epidemiol Biomarkers Prev1994;3:375–9.
Wang SP, Grayston JT. Micro immunofluorescence antibody responses in Chlamydia trachomatis infection. A review. In: Mardh PA, Holmes KK, Oriel JD, et al, eds. Chlamydial infections. Amsterdam, the Netherlands: Elsevier Biomedical Press, 1982:301–6.
Manos MM, Wright DK, Lewis AJ, et al. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In: Furth M, Greaves M, eds. Molecular diagnostics of human cancer. New York, NY: Cold Spring Harbor Press, 1989:209–14.
Roda Husman AM, Walboomers JM, van den Brule AJ, et al. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol1995;76(pt 4):1057–62.
Peeling RW, Kimani J, Plummer F, et al. Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease. J Infect Dis1997;175:1153–8.
Puolakkainen M, Vesterinen E, Purola E, et al. Persistence of chlamydial antibodies after pelvic inflammatory disease. J Clin Microbiol1986;23:924–8.
Ngeow YF. Limitations of serodiagnosis in chlamydial genital tract infections. Ann Acad Med Singapore1996;25:300–4.
Castellsagué X, Bosch FX, Muñoz N. The male role in cervical cancer. Salud Publica Mex2003;45(suppl 3):S345–S353.
World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview & estimates. Geneva, Switzerland: World Health Organization, 2001. (WHO/CDS/CSR/EDC/2001.10). (http://www.who.int/hiv/pub/sti/en/who_hiv_aids_2001.02.pdf).
Centers for Disease Control and Prevention. Sexually transmitted diseases surveillance 2000 supplement: Chlamydia Prevalence Monitoring Project. Atlanta, GA: US Department of Health and Human Services, CDC, 2001.